ofloxacin and clarithromycin

ofloxacin has been researched along with clarithromycin in 198 studies

Research

Studies (198)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	34 (17.17)	18.2507
2000's	98 (49.49)	29.6817
2010's	64 (32.32)	24.3611
2020's	2 (1.01)	2.80

Authors

Authors	Studies
Keserü, GM	1
Nagashima, R; Nishikawa, T; Tobita, M	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S	1
Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT	1
Lombardo, F; Obach, RS; Waters, NJ	1
Jia, L; Sun, H	1
Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M	1
Gikas, A; Psaroulaki, A; Spyridaki, I; Tselentis, Y; Vranakis, I	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Mima, T; Schweizer, HP	1
Glen, RC; Lowe, R; Mitchell, JB	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Barreca, ML; Cannalire, R; Cecchetti, V; Couto, I; Felicetti, T; Machado, D; Manfroni, G; Massari, S; Sabatini, S; Santos Costa, S; Tabarrini, O; Viveiros, M	1
Hammerschlag, MR; Qumei, KK; Roblin, PM	1
Grosset, JH; Ji, B; Perani, EG; Petinon, C	1
Bow, LM; Nicolau, DP; Nightingale, CH; Onyeji, CO; Tessier, PR	1
Dekio, S; Hidaka, T; Kawahara, S; Saito, H; Sato, K; Tomioka, H	1
Graybill, JR; Moreno, F; Valero, G	1
Akiyama, H; Arata, J; Torigoe, R	1
Nicolau, DP; Nightingale, CH; Onyeji, CO; Quintiliani, R	1
Ajiki, Y; Kawada, H; Koga, T; Yasuda, H; Yokota, T	1
Odagiri, S	1
Grosset, JH; Ji, B; Perani, EG; Petinom, C	1
Grosset, JH; Jamet, P; Ji, B; Lienhardt, C; Perani, EG; Petinon, C; Sow, S	1
Citron, DM; Claros, MC; Goldstein, EJ; Hunt Gerardo, S	1
Tanaka, E	1
Drouet, M; Mauffret, N; Nicolie, B	1
Banerjee, DK; McDermott-Lancaster, RD; McKenzie, S	1
Chimura, T	2
Akaki, T; Sato, K; Tomioka, H	2
Akaki, T; Kawahara, S; Sato, K; Shimizu, T; Tomioka, H	1
Appelbaum, PC; Jacobs, MR; Visalli, MA	1
Chen, C; Danziger, LH; Martin, SJ; Pendland, SL; Schreckenberger, PC	2
Kahn, J; Mauriz, Y; Ogilvie, P; Thornsberry, C	1
Dencer, C; Felmingham, D; Ridgway, GL; Robbins, MJ; Salman, H	1
Appelbaum, PC; Jacobs, MR; Lin, G; Spangler, SK	1
Gikas, A; Kofterithis, D; Psaroulaki, A; Spyridaki, I; Tselentis, Y	1
Appelbaum, PC; Clark, CL; Jacobs, MR	1
Agrawal, M; Bhat, N; Dhawan, VK; Nachum, R; Tolbert, L	1
Sato, K; Tomioka, H	1
de Jong, JJ; Endtz, HP; IJzermans, JN; van Gelder, T; Weimar, W	1
Appelbaum, PC; Hoellman, DB; Jacobs, MR; Lin, G	1
Anstey, RJ; Lasko, B; Lau, CY; Martel, A; Reddington, JL; Saint-Pierre, C	1
Akaki, T; Ogasawara, K; Sato, K; Tomioka, H	1
Matsumoto, A; Matsushima, T; Miyashita, N	1
Hatakeyama, S; Oka, T; Suzuki, K; Tachibana, A; Tateda, K; Yamaguchi, K	1
Higashiyama, Y; Hirakata, Y; Kadota, J; Kaneko, Y; Kohno, S; Kuroki, M; Maesaki, S; Miyazaki, Y; Ohno, H; Sawai, T; Tashiro, T; Tomono, K; Yanagihara, K	1
Akaki, T; Kawahara, S; Sato, K; Tomioka, H	1
Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T	1
Kashiwabara, Y; Matsuoka, M; Namisato, M	1
Bowersox, J	1
Asherov, J; Dan, M; Poch, F	1
Enomoto, H; Hasegawa, A; Kawana, H; Kitada, M; Kuriyama, T; Nakamura, H; Ohmori, S; Ohtsuka, T	1
Amthor, M; Burkhardt, U; Ernst, M; Richter, E; Rosahl, W; Rüsch-Gerdes, S; Schreiber, J; Zugehör, M	1
Bharani, A; Kumar, H	1
Hammerschlag, MR; Kutlin, A; Roblin, PM	1
Sano, C; Sano, K; Sato, K; Shimizu, T; Tomioka, H	1
Ishii, Y; Kobayashi, T; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K	1
Busman, TA; Dattani, D; Devcich, KJ; Gotfried, MH; Notario, GF; Palmer, RN; Riffer, E	1
Brade, V; Enzensberger, R; Gruschke, A	1
Weiss, LR	1
Cabré, X; Falguera, M; Ferrer, G; Pérez, J; Ruiz, A; Sacristán, O; Vallverdú, M	1
Dailloux, M; Dauendorffer, JN; Laurain, C; Weber, M	1
Cabria, F; Esteban, J; Fernández-Roblas, R; Gadea, I; Rollan, E; Santos-O'Connor, FG; Soriano, F; Torres, MV	1
Al-Khatib, SM; Allen LaPointe, NM; Califf, RM; Curtis, LH; Dans, PE; Hutchison, S; Schulman, KA; Sendersky, V; Usdin Yasuda, S; Woosley, RL; Wright, A; Østbye, T	1
Katouno, Y; Kobayashi, Y; Sugita, K; Uchida, H	1
Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y	1
Malcolm, C; Marrie, TJ	1
Hata, K; Hisamori, S; Inoue, T; Ishimaru, H; Katoh, K; Maeda, Y; Maniwa, K; Minaguchi, M; Oida, K; Sakuramoto, M; Taguchi, Y; Tanaka, E; Terada, K	1
Itoh, Y; Kikuchi, K; Nakanishi, K; Nakao, S; Ohsaki, Y; Osanai, S; Saito, K; Sato, M; Tachibana, M; Takahashi, T; Toyoshima, E	1
Hasegawa, M; Kobayashi, I; Matsuzaki, K; Sato, Y; Shikano, M; Watabe, E; Yamanaka, N; Yoshimori, K	1
Aoyama, N; Fukuda, M; Kachi, M; Kasuga, M; Kuroda, K; Maekawa, S; Miki, I; Shirasaka, D; Tamura, T; Wambura, C; Watanabe, Y	1
Inoue, K; Kumakura, S; Tsutsui, T; Uchida, M	1
Branca, G; Cammarota, G; Cannizzaro, O; Cesaro, P; Cianci, R; di Caro, S; Fedeli, P; Gasbarrini, G; Lecca, PG; Martino, A	1
Bormann, G; Marsch, WC	1
Bagnardi, V; Botteri, E; Carobbio, A; Corrao, G; Falcone, C; Leoni, O; Zambon, A	1
Branca, G; Cammarota, G; Fadda, G; Gasbarrini, A; Gasbarrini, GB; Schito, AM; Spanu, T	1
Accornero, L; Bilardi, C; Dulbecco, P; Iiritano, E; Mamone, M; Mansi, C; Parodi, A; Reglioni, S; Savarino, E; Savarino, V; Vigneri, S; Zentilin, P	1
Miravitlles, M; Torres, A	1
Eller, J; Ioanas, M; Linnhoff, A; Lode, H	1
González-Granda, D; Labrador, T; Martínez, I; Nieto, A; Querol-Borrás, JM; Querol-Ribelles, JM; Tenías, JM	1
Candelli, M; Carloni, E; Cazzato, A; Di Campli, C; Fini, L; Gasbarrini, A; Gasbarrini, G; Nista, EC; Pignataro, G; Zocco, MA	1
Armstrong, EP; Malone, DC; Ramachandran, S; Skrepnek, GH	1
Nakagawa, T; Ogawa, K; Taga, S; Tano, M	1
De Vecchi, E; Drago, L; Legnani, D; Nicola, L; Prenna, M; Ripa, S	1
Fakokunde, A; Gyang, A; Kalu, E; Whitlow, B	1
Bhusal, Y; Shiohira, CM; Yamane, N	1
Antos, D; Bästlein, E; Bayerdörffer, E; Buchner, M; Haferland, C; Hänel, C; Lehn, N; Meier, E; Schneider-Brachert, W; Stolte, M; Trump, F	1
Díaz F, A; Pavié G, J; Prida C, JM; Saldías P, F	1
Benito, LM; Bermejo, F; Bory, F; Castro-Fernández, M; Cosme, A; Ducons, J; Fernández-Bermejo, M; Gisbert, JP; Lamas, E; López-Rivas, L; Olivares, D; Pabón, M; Pérez-Aisa, A	1
Baum, GL; Daniele, B; Kramer, MR; Lavy, A; Priess, R; Raz, M; Shitrit, AB; Shitrit, D; Shlomi, D	1
Blasi, F; Tarsia, P	1
Mikamo, H; Tamaya, T; Tanaka, K; Watanabe, K	1
Cammarota, G; Candelli, M; Cazzato, A; Finizio, R; Gabrielli, M; Gasbarrini, A; Gasbarrini, G; Lauritano, EC; Nista, EC; Ojetti, V; Santoro, M; Zocco, MA	1
Avgoustinaki, N; Boutli-Kasapidou, F; Delli, F; Karakatsanis, G; Lambrou, N; Tsatsos, M	1
Komori, K; Miyajima, K; Nakada, N; Suzuki, Y; Tanaka, H; Yamashita, N; Yasojima, M	1
Komori, K; Nakada, N; Suzuki, Y; Tanaka, H; Yasojima, M	1
Pistiolas, D; Robotis, J; Rokkas, T; Sechopoulos, P	1
Cammarota, G; Candelli, M; Cremonini, F; Finizio, R; Gasbarrini, A; Gasbarrini, G; Nista, EC; Ojetti, V; Spada, C; Zocco, MA	1
Gidoh, M; Matsuoka, M; Yamazaki, T	1
Eguchi, K; Fujikawa, K; Fukuda, T; Motomura, M; Ooe, N; Suenaga, A	1
Falguera, M; Giménez, A; Gómez-Arbonés, X; Porcel, JM; Ruiz-González, A; Sánchez, V; Soler-González, J	1
Tam, WO; Tse, TF; Wong, PC; Yam, WC; Yew, WW; Yuen, KY	1
Gagnon, C; García-Ac, A; Ghosh, D; Lajeunesse, A; Sauvé, S; Segura, PA	1
Hassan, C; Morini, S; Perna, F; Ricci, C; Saracino, I; Vaira, D; Zullo, A	1
Altiparmak, UE; Aslan, BS; Duman, S; Ozer, PA; Ozkuyumcu, C; Us, AD	1
Cannaviello, C; De Francesco, V; Efrati, C; Hassan, C; Ierardi, E; Maconi, G; Manes, G; Morini, S; Panella, C; Piglionica, D; Scaccianoce, G; Zullo, A	1
Chang, WL; Chen, WY; Cheng, HC; Sheu, BS; Wu, JJ; Yang, HB	1
Bozzi, R; Cozzolino, A; Di Girolamo, E; Morante, A; Pasquale, L; Rispo, A	1
Fukushima, K; Higashiyama, Y; Hirakata, Y; Kohno, S; Kohno, Y; Miyazaki, Y; Ohno, H; Yanagihara, K	1
Almela, P; Barrio, J; Benito, LM; Bermejo, F; Bory, F; Calvet, X; Carneros, JA; Castro-Fernández, M; Cosme, A; Fernández-Bermejo, M; Franco, A; García-Durán, F; Gisbert, JP; Khorrami, S; Lamas, E; Modolell, I; Niño, P; O'Callaghan, E; Ortiz, V; Ortuño, J; Pérez-Aisa, A; Ponce, J; Rodrigo, L; Sánchez-Pobre, P; Tomas, A; Valer, MP	1
Appelbaum, PC; Clark, CL; Ednie, LM; Kosowska-Shick, K	1
Arguedas, A; Blumer, JL; Bradley, JS; Melkote, R; Noel, GJ; Sáez-Llorens, X	1
Dediste, A; Portaels, F; Rigouts, L; Shamputa, IC; Struelens, M; Umubyeyi, A	1
Gigliotti, F; Morini, S; Ricci, C; Vaira, D; Zullo, A	1
Chan, FK; Lee, CC; Lee, VW; Ling, TK	1
Baba, T; Endo, T; Hagiwara, E; Komatsu, S; Matsumoto, Y; Nishihira, R; Ogura, T; Sato, T; Sekine, A; Shinohara, T; Sogo, Y; Takahashi, H	1
Gopinath, K; Sankar, MM; Singh, S; Singla, R	1
Cozzolino, D; Iovene, MR; Nardone, G; Pilloni, AP; Rocco, A; Romano, M; Russo, MI; Salerno, R; Tufano, MA; Vaira, D	1
Hagymási, K; Tulassay, Z	1
Dubrovskaia, NV; Dvoretskiĭ, LI; Filimonova, OIu; Grudinina, SA; Iakovlev, SV; Sidorenko, SV	1
Coelho, L; Moretzsohn, L; Sanches, B; Vieira, G	1
Noguchi, Y	1
Elias, N; Odeh, M; Sabetay, S; Sheikh-Ahmad, M; Slobodin, G; Weller, B; Zaygraikin, N	1
Gu, CP; Huang, LP; Zhuang, ML	1
de Boer, WA; Janssen, MJ; Schrauwen, RW	1
Chang, WL; Cheng, HC; Sheu, BS; Wu, JJ; Yang, HB; Yang, YJ	1
Barrio, J; Castro-Fernández, M; Cosme, A; Gisbert, JL; Gisbert, JP; Marcos, S; Moreno-Otero, R; Pérez-Aisa, A; Rodrigo, L	1
Katelaris, PH	1
Kandulski, A; Malfertheiner, P; Selgrad, M	1
Allerheiligen, V; Cambau, E; Corbel, C; Coulon, C; Deforges, L; Delchier, JC; Lascols, C; Megraud, F; Soussy, CJ	1
But, D; Chan, CK; Chan, FS; Chan, P; Cheung, TK; Chu, KM; Gu, Q; Hsu, A; Hung, IF; Leung, S; Seto, WK; Tong, TS; Wong, BC; Wong, SY	1
Angelini, R; Pontone, P; Pontone, S; Standoli, M	1
Cristofari, F; De Francesco, V; Giorgio, F; Hassan, C; Ierardi, E; Panella, C; Perna, F; Vaira, D; Vannella, L; Zullo, A	1
Castanheira, M; Jones, RN; Woosley, LN	1
Abadia, EG; Dueñas, C; Fernandez-Bermejo, M; Gisbert, JP; Gonzalez-Garcia, G; Hernandez-Alonso, M; Mateos-Rodriguez, JM; Molina-Infante, J; Perez-Gallardo, B; Vinagre, G	1
Levy, I; Samra, Z; Shmuely, H; Yahav, J; Zevit, N	1
Arnold, F; Griffin, AT; Peyrani, P; Wiemken, T	1
Hibi, T; Nishizawa, T; Suzuki, H	1
Chang, CY; Chen, CC; Chen, MJ; Cheng, TY; Lee, YC; Lin, JT; Liou, JM; Sheng, WH; Wang, HP; Wu, MS	1
D'Ercole, C; De Francesco, V; Hassan, C; Vaira, D; Zullo, A	1
Abdelfatah, M; Assem, M; El Azab, G; Rasheed, MA; Shastery, M	1
Huang, X; Li, Y; Shi, R; Yao, L; Zhang, G	1
Hsueh, PR; Lee, PI; Yang, JC	1
Gisbert, JP; Pajares, JM	1
Chang, JJ; Chang, LC; Chen, LW; Chien, RN; Fang, KM	1
Baldelli, R; Cevenini, R; D'Antuono, A; Delucca, F; Di Francesco, A; Donati, M; Moroni, A; Shurdhi, A	1
Araj, GF; Awar, GN; Baban, TA; Kanj, SS; Naba, MR; Tabbarah, ZA	1
Cuomo, A; Federico, A; Gravina, AG; Iovene, MR; Marmo, R; Miranda, A; Nardone, G; Rocco, A; Romano, M; Salerno, R; Sica, M; Tiso, A	1
Gu, WQ; Liang, X; Liu, WZ; Lu, H; Sun, QJ; Xiao, SD; Zheng, Q	1
Hagiwara, E; Komatsu, S; Ogura, T; Sawahata, M; Sekine, A; Takahashi, H; Tsuchiya, N	1
Chang, CY; Chang, SC; Chen, MJ; Chian, H; Hung, HW; Lee, YC; Lin, JT; Liou, JM; Sheng, WH; Wang, YC; Wu, MS	1
Gisbert, JP; Molina-Infante, J	1
De Francesco, V; Vaira, D; Zullo, A	1
Ishii, Y; Kimura, S; Sato, T; Tateda, K; Yamaguchi, K	1
Lochmannová, J	1
Baik, GH; Jung, HC; Kim, GH; Kim, HB; Kim, JM; Kim, JY; Kim, NY; Kim, SJ; Lee, DH; Nam, RH; Song, IS	1
Dan, M; Rosenberg, S; Samra, Z	1
Goh, KL; Navaratnam, P	1
Girdhar, A; Girdhar, BK; Kumar, A	1
Choi, KH; Chung, WC; Jung, SH; Kang, BK; Kim, EJ; Lee, KM; Oak, JH; Paik, CN	1
Armstrong, WS; Eaton, ME; Kelley, CF	1
Bauerfeind, P; Kaiser, P; Misselwitz, B; Vavricka, SR	1
Budak, A; Karczewska, E; Sito, E; Wojtas-Bonior, I; Zwolińska-Wcisło, M	1
Basu, PP; Flynn, M; Krishnaswamy, N; Pacana, T; Rayapudi, K; Shah, NJ	1
Chuah, SK; Hsu, PI; Tsay, FW; Wu, DC	1
Hoshino, Y; Ishii, N; Nakanaga, K; Onoe, H; Takeuchi, T; Yotsu, RR	1
Andries, K; Bantubani, N; De Marez, T; Diacon, AH; Donald, PR; Grobusch, M; Lounis, N; Mahanyele, R; McNeeley, DF; Meyvisch, P; Narasimooloo, R; Patientia, RF; Pym, A; van Heeswijk, R	1
Fung, BK; Ip, WY; Omoruyi, OJ	1
D'Arcy, S; Glocker, E; Lasseter, G; Lawson, AJ; McNulty, CA; Nichols, T; Shaw, I	1
Andersen, LP; Coenen, S; Glupczynski, Y; Goossens, H; Hirschl, AM; Kist, M; Lopez-Brea, M; Megraud, F; Versporten, A	1
Hassan, G; Kant, S; Parengal, J; Saheer, S	1
Almela, P; Barrio, J; Bermejo, F; Bory, F; Calvet, X; Castro-Fernández, M; Cosme, A; Fernández-Bermejo, M; Franco, A; Gisbert, JP; Guerra, I; Khorrami, S; Lamas, E; Modolell, I; Ortuño, J; Pérez-Aisa, A; Ponce, J; Rodrigo, L; Sánchez-Pobre, P; Tomas, A	1
Aresti-Zárate, S; Ayestarán, B; Campos, MR; Carrascosa, MF; Cobo, M; Cuadrado-Lavín, A; Dierssen-Sotos, T; Fernández-Pousa, A; González-Colominas, E; Hernández, M; Pascual, EL; Salcines-Caviedes, JR	1
Kato, S; Kobashi, Y; Mouri, K; Obase, Y; Oka, M	1
Buzás, GM	1
Azzolini, F; Bedogni, G; Camellini, L; Cavina, M; Decembrino, F; Di Mario, F; Formisano, D; Iori, V; Sassatelli, R; Sereni, G; Tioli, C	1
Cerqueira, RM; Correia, MR; Fernandes, CD; Manso, MC; Vilar, H	1
Chang, CY; Chang, WH; Chen, CC; Chen, MJ; Fang, YJ; Hsu, SJ; Hsu, YC; Lee, JY; Lee, YC; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Tseng, CH; Tseng, PH; Wang, HP; Wu, MS; Yang, UC	1
Breurec, S; Burucoa, C; Dia, D; Mbengue, M; Onambele, M; Raymond, J; Seck, A	1
Imai, Y; Inokuma, T; Matsumoto, T	1
Gisbert, JP; Marin, AC; McNicholl, AG	1
Carratelli, CR; Iovene, MR; Losacco, A; Rizzo, A	1
Fujii, R; Ishihara, K; Narita, M; Okuda, K; Shibahara, T; Takano, N	1
Shokri-Shirvani, J; Zamani, M; Zamani, V	1
Chiron, S; de Melo Costa Serge, N; Goetz, V; Li, C; Nogueira, RFP	1
Jiang, B; Jing, XL; Li, GA; Li, SS; Ling, WC; Sui, SS; Sun, CY; Wang, YL	1

Reviews

17 review(s) available for ofloxacin and clarithromycin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[In vitro antimicrobial activities of quinolones, rifamycins and macrolides against Mycobacterium tuberculosis and M.avium complex: attempt to establish new assay methods which accurately reflect therapeutic effects of test agents in vivo]. Kekkaku : [Tuberculosis], 1999, Volume: 74, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cells, Cultured; Clarithromycin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Ofloxacin; Rifamycins	1999
Treatment of H. pylori infection: a review. Current medicinal chemistry, 2005, Volume: 12, Issue:4 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bismuth; Clarithromycin; Fluoroquinolones; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Ofloxacin; Polypharmacy; Ranitidine; Rifabutin	2005
Value of short-course antimicrobial therapy in community-acquired pneumonia. International journal of antimicrobial agents, 2005, Volume: 26 Suppl 3 Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Microspheres; Ofloxacin; Pneumonia; Time Factors; Treatment Outcome	2005
[Treatment for Helicobacter pylori: current criteria]. Recenti progressi in medicina, 2007, Volume: 98, Issue:11 Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Metronidazole; Ofloxacin; Practice Guidelines as Topic; Proton Pump Inhibitors; Quinolones; Tinidazole; Treatment Outcome	2007
[The new aspects of the eradication of Helicobacter pylori and the importance of bacterial resistance]. Orvosi hetilap, 2008, Oct-26, Volume: 149, Issue:43 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Patient Compliance; Proton Pump Inhibitors; Risk Factors; Salvage Therapy; Treatment Failure	2008
[Pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections]. Nihon rinsho. Japanese journal of clinical medicine, 2009, Volume: 67, Issue:1 Topics: Anti-Bacterial Agents; Azithromycin; Bacteriological Techniques; Cephalosporins; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Therapy, Combination; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Nucleic Acid Amplification Techniques; Ofloxacin; Pharyngitis; Pregnancy; Pregnancy Complications, Infectious; Sexual Behavior	2009
Helicobacter pylori: diagnosis and treatment. Current opinion in gastroenterology, 2009, Volume: 25, Issue:6 Topics: Amoxicillin; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ofloxacin; Practice Guidelines as Topic; Proton Pump Inhibitors; Rifabutin; Treatment Failure	2009
Helicobacter pylori eradication therapy. Future microbiology, 2010, Volume: 5, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Ranitidine; Tetracycline; Treatment Failure; Treatment Outcome	2010
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis. Wiener klinische Wochenschrift, 2010, Volume: 122, Issue:13-14 Topics: Anti-Infective Agents; Aza Compounds; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Proton Pump Inhibitors; Quinolines; Randomized Controlled Trials as Topic; Recurrence; Retreatment	2010
Treatment of Helicobacter pylori infection: the past and the future. European journal of internal medicine, 2010, Volume: 21, Issue:5 Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ofloxacin	2010
[Pulmonary mycobacteriosis caused by Mycobacterium peregrinum in a young, healthy man]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2010, Volume: 48, Issue:11 Topics: Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Levofloxacin; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult	2010
[Current perspective of the resistance of Helicobacter pylori strains to antimicrobial drugs]. Klinicka mikrobiologie a infekcni lekarstvi, 2010, Volume: 16, Issue:6 Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors	2010
[New options for helicobacter pylori antibiotic treatment]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:28-29 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ofloxacin; Precision Medicine; Proton Pump Inhibitors; Retreatment; Stomach Diseases; Treatment Failure	2011
A new look at anti-Helicobacter pylori therapy. World journal of gastroenterology, 2011, Sep-21, Volume: 17, Issue:35 Topics: Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Tetracycline	2011
[Helicobacter pylori - 2012]. Orvosi hetilap, 2012, Sep-09, Volume: 153, Issue:36 Topics: Algorithms; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Emigrants and Immigrants; Endoscopy, Gastrointestinal; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Hungary; In Situ Hybridization, Fluorescence; Levofloxacin; Ofloxacin; Peptic Ulcer; Polymerase Chain Reaction; Stomach Neoplasms	2012
A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication). Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:7 Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Treatment Failure	2013

Trials

34 trial(s) available for ofloxacin and clarithromycin

Article	Year
Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:9 Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Leprosy, Lepromatous; Male; Mice; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Skin	1996
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial]. Kekkaku : [Tuberculosis], 1996, Volume: 71, Issue:9 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Kanamycin; Mycobacterium avium-intracellulare Infection; Ofloxacin; Pilot Projects; Rifampin; Tuberculosis, Pulmonary	1996
Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group. The Journal of international medical research, 1998, Volume: 26, Issue:6 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Sinusitis; Treatment Outcome	1998
Crossover assessment of serum bactericidal activity of grepafloxacin, ofloxacin and clarithromycin against respiratory pathogens after oral administration to healthy volunteers. International journal of antimicrobial agents, 2001, Volume: 17, Issue:6 Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Blood Bactericidal Activity; Clarithromycin; Cross-Over Studies; Female; Fluoroquinolones; Haemophilus influenzae; Humans; In Vitro Techniques; Klebsiella pneumoniae; Male; Moraxella catarrhalis; Ofloxacin; Penicillin Resistance; Piperazines; Respiratory Tract Infections; Streptococcus pneumoniae	2001
A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia. Clinical therapeutics, 2002, Volume: 24, Issue:5 Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Treatment Outcome	2002
Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis. Clinical therapeutics, 2002, Volume: 24, Issue:9 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bronchitis, Chronic; Cefuroxime; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome	2002
[Community-acquired pneumonia: usefulness of clinical presentation in the selection of antibiotic treatment]. Medicina clinica, 2002, Nov-16, Volume: 119, Issue:17 Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Community-Acquired Infections; Female; Hospitalization; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Ofloxacin; Penicillins; Pneumonia, Bacterial; Treatment Outcome	2002
High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication. Journal of clinical gastroenterology, 2004, Volume: 38, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Omeprazole; Rabeprazole; Treatment Outcome	2004
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2004, Volume: 2, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Organometallic Compounds; Pantoprazole; Prospective Studies; Sulfoxides; Treatment Outcome	2004
Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval. The European respiratory journal, 2004, Volume: 24, Issue:6 Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Progression; Double-Blind Method; Female; Germany; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Statistics, Nonparametric; Treatment Outcome	2004
Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization. International journal of antimicrobial agents, 2005, Volume: 25, Issue:1 Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Cohort Studies; Community-Acquired Infections; Drug Therapy, Combination; Female; Hospitalization; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome	2005
7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity. Helicobacter, 2006, Volume: 11, Issue:1 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome	2006
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures. The American journal of gastroenterology, 2006, Volume: 101, Issue:2 Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure	2006
Rifaximin-based regimens for eradication of Helicobacter pylori: a pilot study. Digestive diseases (Basel, Switzerland), 2006, Volume: 24, Issue:1-2 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pilot Projects; Rifamycins; Rifaximin; Treatment Outcome	2006
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication. The American journal of gastroenterology, 2006, Volume: 101, Issue:9 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome	2006
Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease. Respirology (Carlton, Vic.), 2007, Volume: 12, Issue:1 Topics: Amoxicillin; Anti-Infective Agents; Cefuroxime; Clarithromycin; Female; Follow-Up Studies; Forced Expiratory Volume; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Oximetry; Pulmonary Disease, Chronic Obstructive; Quality of Life; Recurrence; Survival Rate; Time Factors; Treatment Outcome	2007
Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2007, Volume: 39, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Levofloxacin; Male; Middle Aged; Ofloxacin; Rabeprazole; Tinidazole; Treatment Outcome	2007
Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy. Helicobacter, 2007, Volume: 12, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Constipation; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Nausea; Ofloxacin; Treatment Outcome; Vomiting	2007
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients. The American journal of gastroenterology, 2008, Volume: 103, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure; Urea	2008
Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia. The Pediatric infectious disease journal, 2007, Volume: 26, Issue:10 Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Ofloxacin; Pneumonia; Treatment Outcome	2007
Failure of Helicobacter pylori treatment after regimes containing clarithromycin: new practical therapeutic options. Helicobacter, 2008, Volume: 13, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Doxycycline; Female; Furazolidone; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Organometallic Compounds; Prospective Studies; Rabeprazole; Treatment Failure; Treatment Outcome; Urea	2008
Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong? Helicobacter, 2009, Volume: 14, Issue:6 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin	2009
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome	2010
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2010, Volume: 31, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Treatment Outcome; Young Adult	2010
Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design. Gut, 2010, Volume: 59, Issue:5 Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Cross-Over Studies; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Treatment Outcome; Young Adult	2010
Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study. European journal of internal medicine, 2010, Volume: 21, Issue:4 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Single-Blind Method; Young Adult	2010
Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study. International journal of clinical practice, 2010, Volume: 64, Issue:11 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome	2010
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Gut, 2010, Volume: 59, Issue:11 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Costs; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome; Young Adult	2010
A randomised controlled trial assessing the effect of adding clarithromycin to rifampicin, ofloxacin and minocycline in the treatment of single lesion paucibacillary leprosy in Agra District, India. Leprosy review, 2011, Volume: 82, Issue:1 Topics: Adolescent; Adult; Child; Child, Preschool; Clarithromycin; Female; Humans; India; Leprosy, Paucibacillary; Male; Middle Aged; Minocycline; Ofloxacin; Recurrence; Rifampin; Survival Analysis; Treatment Outcome	2011
Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial. Journal of Korean medical science, 2011, Volume: 26, Issue:6 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Peptic Ulcer; Prospective Studies; Rifamycins; Rifaximin	2011
A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori. The American journal of gastroenterology, 2011, Volume: 106, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Lansoprazole; Levofloxacin; Male; Middle Aged; Nitro Compounds; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Recurrence; Thiazoles; Young Adult	2011
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6 Topics: Antitubercular Agents; Clarithromycin; Cycloserine; Dapsone; Diarylquinolines; Erythromycin; Female; Humans; Isoxazoles; Male; Ofloxacin; Oxazolidinones; Quinolines; Tuberculosis, Multidrug-Resistant	2012
Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:9 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors; Single-Blind Method; Spain; Time Factors; Treatment Outcome; Urea; Young Adult	2012
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet (London, England), 2013, Jan-19, Volume: 381, Issue:9862 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Ofloxacin	2013

Other Studies

147 other study(ies) available for ofloxacin and clarithromycin

Article	Year
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16 Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship	2003
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors. Bioorganic & medicinal chemistry letters, 2005, Jun-02, Volume: 15, Issue:11 Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated	2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen	2007
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Support vector machines classification of hERG liabilities based on atom types. Bioorganic & medicinal chemistry, 2008, Jun-01, Volume: 16, Issue:11 Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve	2008
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis	2009
Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6 Topics: Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Coxiella burnetii; Humans; Microbial Sensitivity Tests; Minocycline; Q Fever; Tigecycline; Vero Cells	2009
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Burkholderia pseudomallei; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Periplasmic Proteins; Quorum Sensing; Singapore; Virulence Factors	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium. European journal of medicinal chemistry, 2017, Nov-10, Volume: 140 Topics: Anti-Bacterial Agents; Drug Design; Genistein; Mycobacterium avium; Quinolones	2017
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:7 Topics: Anti-Bacterial Agents; Azithromycin; Cells, Cultured; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Ofloxacin	1992
Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1992, Volume: 60, Issue:4 Topics: Animals; Clarithromycin; Disease Models, Animal; Female; Fluoroquinolones; Foot; Hindlimb; Immunocompetence; Leprostatic Agents; Leprosy; Mice; Microbial Sensitivity Tests; Minocycline; Mycobacterium leprae; Ofloxacin; Quinolones; Rifampin	1992
Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare. The Journal of infectious diseases, 1995, Volume: 172, Issue:3 Topics: Azithromycin; Cells, Cultured; Clarithromycin; Dose-Response Relationship, Drug; Drug Carriers; Drug Interactions; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Kinetics; Liposomes; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Ofloxacin; Recombinant Proteins; Time Factors	1995
Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice. Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1995, Volume: 76, Issue:1 Topics: Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Drug Synergism; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolones; Rifamycins; Streptomycin	1995
Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:11 Topics: Animals; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Skin Diseases, Bacterial; Splenic Diseases	1994
Interaction of Staphylococcus aureus cells and silk threads in vitro and in mouse skin. Journal of dermatological science, 1993, Volume: 6, Issue:3 Topics: Animals; Bacterial Adhesion; Biopsy; Cell Communication; Chlorhexidine; Clarithromycin; Cyclophosphamide; Female; Formaldehyde; Insect Proteins; Mice; Microscopy, Electron; Ofloxacin; Povidone-Iodine; Proteins; Silk; Skin; Staphylococcus aureus; Textiles	1993
Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:3 Topics: Clarithromycin; Colony Count, Microbial; Drug Carriers; Ethambutol; Humans; In Vitro Techniques; Liposomes; Macrophages; Mycobacterium avium Complex; Ofloxacin	1994
Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:9 Topics: Alginates; Animals; Bacterial Proteins; Clarithromycin; Filtration; Hexoses; Male; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Skin	1993
Levofloxacin in patients with severe respiratory tract infection. Drugs, 1995, Volume: 49 Suppl 2 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Asthma; Bronchitis; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pseudomonas aeruginosa; Respiratory Tract Infections	1995
Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:2 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Colony Count, Microbial; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Leprostatic Agents; Leprosy; Mice; Mice, Nude; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin	1996
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:10 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Clarithromycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Streptococcus pneumoniae	1996
[Unusual clinical form of amoxicillin allergy]. Allergie et immunologie, 1996, Volume: 28, Issue:9 Topics: Amoxicillin; Clarithromycin; Drug Eruptions; Drug Therapy, Combination; Edema; Female; Humans; Methylprednisolone; Ofloxacin; Pruritus; Skin Tests; Stomatitis; Vulvovaginitis	1996
Experimental evaluation of possible new short-term drug regimens for treatment of multibacillary leprosy. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:2 Topics: Animals; Clarithromycin; Drug Therapy, Combination; Leprostatic Agents; Leprosy; Mice; Mice, Nude; Mycobacterium leprae; Ofloxacin; Rifampin	1997
[Measurement of antibody titers to chlamydial infection and effects of levofloxacin in cystic cervicitis and chlamydial infection]. The Japanese journal of antibiotics, 1997, Volume: 50, Issue:5 Topics: Actihaemyl; Administration, Oral; Adolescent; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Chlamydia Infections; Chlamydia trachomatis; Chloramphenicol; Clarithromycin; Drug Therapy, Combination; Female; Humans; Immunoglobulin A; Immunoglobulin G; Levofloxacin; Middle Aged; Ofloxacin; Pessaries; Pregnancy; Pregnancy Complications, Infectious; Uterine Cervicitis	1997
[Anti-Mycobacterium avium complex activities of KRM-1648, clarithromycin and levofloxacin in 7HSF medium at peak or average blood concentrations after their oral administration of clinical dosages]. Kekkaku : [Tuberculosis], 1997, Volume: 72, Issue:7 Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Clarithromycin; Culture Media; Humans; Levofloxacin; Mycobacterium avium Complex; Ofloxacin; Rifamycins	1997
[In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice]. Kekkaku : [Tuberculosis], 1997, Volume: 72, Issue:8 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antitubercular; Clarithromycin; Diclofenac; Drug Therapy, Combination; Female; Levofloxacin; Mice; Mice, Inbred BALB C; Mycobacterium avium; Ofloxacin; Rifamycins; Tuberculosis	1997
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill. Diagnostic microbiology and infectious disease, 1997, Volume: 28, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Sensitivity and Specificity; Species Specificity; Streptococcus pneumoniae	1997
Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones. Journal of clinical microbiology, 1997, Volume: 35, Issue:11 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Charcoal; Ciprofloxacin; Clarithromycin; Culture Media; Erythromycin; Humans; Legionella; Legionella pneumophila; Legionellosis; Microbial Sensitivity Tests; Ofloxacin; Reproducibility of Results; Starch	1997
In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin. Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; In Vitro Techniques; Legionella; Legionella pneumophila; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin	1997
Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group. Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:4 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Clarithromycin; Cohort Studies; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Ofloxacin; Respiratory Tract Infections; Streptococcus pneumoniae; United States	1997
The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp. The Journal of antimicrobial chemotherapy, 1997, Volume: 40 Suppl A Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia; Clarithromycin; Dose-Response Relationship, Drug; Doxycycline; Fluoroquinolones; Gram-Negative Bacteria; Legionella; Mycoplasma; Ofloxacin; Piperazines; Quinolones; Ureaplasma urealyticum	1997
Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:1 Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Female; Levofloxacin; Lung; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium avium; Ofloxacin; Phagocytosis; Rifamycins; Tuberculosis	1998
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae	1998
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:10 Topics: Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Coxiella burnetii; Doxycycline; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pefloxacin	1998
Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies. Journal of clinical microbiology, 1998, Volume: 36, Issue:12 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbon Dioxide; Clarithromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae	1998
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients. The Western journal of medicine, 1998, Volume: 169, Issue:5 Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Bisexuality; Black People; Cephalexin; Cephalosporins; Clarithromycin; Dicloxacillin; Doxycycline; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Homosexuality, Male; Humans; Male; Metronidazole; Middle Aged; Ofloxacin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; White People	1998
Atypical mycobacterium infection with dermatological manifestation in a renal transplant recipient. Transplant international : official journal of the European Society for Organ Transplantation, 1999, Volume: 12, Issue:1 Topics: Clarithromycin; Drug Therapy, Combination; Ethambutol; Foot; Humans; Kidney Transplantation; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Postoperative Complications; Rifampin; Skin Diseases, Bacterial	1999
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents. The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:5 Topics: Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae	1999
[MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines]. Kekkaku : [Tuberculosis], 1999, Volume: 74, Issue:7 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cells, Cultured; Clarithromycin; Humans; Levofloxacin; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Ofloxacin; Pulmonary Alveoli; Rifamycins	1999
In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains. Microbiology and immunology, 2000, Volume: 44, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Glycogen; Humans; Male; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Plasmids; Urethritis	2000
[Fibrosing alveolitis following Legionella pneumonia]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2000, Volume: 38, Issue:4 Topics: Anti-Inflammatory Agents; Clarithromycin; Drug Therapy, Combination; Humans; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Minocycline; Ofloxacin; Pulmonary Fibrosis; Pulse Therapy, Drug; Steroids; Treatment Outcome	2000
Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation. The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:1 Topics: Animals; Biofilms; Chronic Disease; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Intubation; Levofloxacin; Male; Mice; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections	2000
Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines. International journal of antimicrobial agents, 2000, Volume: 16, Issue:1 Topics: Anti-Bacterial Agents; Cell Line; Clarithromycin; Epithelial Cells; Humans; Levofloxacin; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis; Ofloxacin; Pulmonary Alveoli; Rifamycins; Tuberculosis	2000
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture]. The Japanese journal of antibiotics, 2000, Volume: 53, Issue:12 Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins	2000
A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 2000, Volume: 68, Issue:4 Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Colony Count, Microbial; Dapsone; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Leprostatic Agents; Leprosy; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mycobacterium leprae; Ofloxacin; Rifampin	2000
CPCRA researchers present OI studies at Vancouver. NIAID AIDS agenda, 1996 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Candidiasis; Child; Clarithromycin; Clinical Trials as Topic; DNA, Viral; Drug Therapy, Combination; Ethambutol; Female; Fluconazole; Humans; Isoniazid; Molluscum Contagiosum; Molluscum contagiosum virus; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Ofloxacin; Patient Compliance; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Tuberculosis	1996
Effect of levofloxacin on theophylline clearance during theophylline and clarithromycin combination therapy. The Annals of pharmacotherapy, 2001, Volume: 35, Issue:6 Topics: Anti-Infective Agents; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Emphysema; Humans; Levofloxacin; Male; Metabolic Clearance Rate; Middle Aged; Ofloxacin; Theophylline	2001
[Non-tubercular mycobacterial infection of the lungs due to Mycobacterium smegmatis]. Pneumologie (Stuttgart, Germany), 2001, Volume: 55, Issue:5 Topics: Cardiopulmonary Resuscitation; CD4-Positive T-Lymphocytes; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Ofloxacin; Radiography; Rifabutin	2001
Drug points: Diabetes inspidus induced by ofloxacin. BMJ (Clinical research ed.), 2001, Sep-08, Volume: 323, Issue:7312 Topics: Adult; Anti-Infective Agents, Urinary; Clarithromycin; Diabetes Insipidus; Drug Therapy, Combination; Gentamicins; Humans; Male; Metronidazole; Ofloxacin; Penicillin G; Pneumonia, Pneumococcal	2001
Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:2 Topics: Anti-Bacterial Agents; Azithromycin; Chlamydophila pneumoniae; Clarithromycin; Cytokines; Humans; Levofloxacin; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Tumor Cells, Cultured	2002
Intramacrophage passage of Mycobacterium tuberculosis and M. avium complex alters the drug susceptibilities of the organisms as determined by intracellular susceptibility testing using macrophages and type II alveolar epithelial cells. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:2 Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cells, Cultured; Clarithromycin; Epithelial Cells; Humans; Levofloxacin; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Ofloxacin; Rifamycins	2002
Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2000, Volume: 6, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Proteins; Ceftazidime; Cephalosporins; Clarithromycin; Clindamycin; Erythromycin; In Vitro Techniques; Josamycin; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Oleandomycin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Time Factors; Tobramycin	2000
[Changes of antibody titers during antimicrobial therapy including levofloxacin for Chlamydia infections in the obstetrics and gynecology field]. The Japanese journal of antibiotics, 2002, Volume: 55, Issue:2 Topics: Antibodies, Bacterial; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Levofloxacin; Maternal-Fetal Exchange; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious	2002
[Osteomyelitis of the tibial head caused by Mycobacterium haemophilium in a patient with AIDS]. Deutsche medizinische Wochenschrift (1946), 2002, Sep-20, Volume: 127, Issue:38 Topics: Abscess; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections; Ofloxacin; Osteomyelitis; Recurrence; Rifabutin; Tibia	2002
In vitro sensitivity of Mycobacterium xenopi to five antibiotics. Pathologie-biologie, 2002, Volume: 50, Issue:10 Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Ofloxacin; Rifampin	2002
A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Mycobacterium fortuitum; Ofloxacin; Tetracycline	2002
Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. The American journal of medicine, 2003, Feb-01, Volume: 114, Issue:2 Topics: Adult; Aged; Amitriptyline; Anti-Bacterial Agents; Anti-Infective Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clarithromycin; Cohort Studies; Drug Prescriptions; Drug Synergism; Erythromycin; Female; Fluoxetine; Heart Conduction System; Humans; Male; Middle Aged; Ofloxacin; Outpatients; Polypharmacy; Torsades de Pointes; United States	2003
[Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori]. The Japanese journal of antibiotics, 2002, Volume: 55, Issue:6 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Gastric Mucosa; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Penicillins; Stomach Ulcer	2002
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year]. The Japanese journal of antibiotics, 2001, Volume: 54 Suppl B Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors	2001
[Fluoroquinolone superior to macrolide. Longer infection free period after acute bronchitis]. MMW Fortschritte der Medizin, 2003, Feb-13, Volume: 145, Issue:7 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Bronchitis; Clarithromycin; Double-Blind Method; Follow-Up Studies; Humans; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Recurrence	2003
Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting. Archives of internal medicine, 2003, Apr-14, Volume: 163, Issue:7 Topics: Adolescent; Adult; Aged; Alberta; Ambulatory Care; Analysis of Variance; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Emergency Service, Hospital; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Treatment Outcome	2003
[A case of pulmonaly bulla infection with Mycobacterium fortuitum]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2003, Volume: 77, Issue:6 Topics: Aged; Blister; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Lung Diseases, Interstitial; Minocycline; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Pulmonary Emphysema	2003
Alterations in penicillin binding protein gene of Streptococcus pneumoniae and their correlation with susceptibility patterns. International journal of antimicrobial agents, 2003, Volume: 22, Issue:2 Topics: Aminoacyltransferases; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carrier Proteins; Clarithromycin; Drug Resistance, Bacterial; Genes, Bacterial; Hexosyltransferases; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumococcal Infections; Streptococcus pneumoniae; Thienamycins	2003
[Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs]. The Japanese journal of antibiotics, 2003, Volume: 56, Issue:3 Topics: Acute Disease; Ampicillin; Anti-Infective Agents; Azithromycin; Cefdinir; Cefpodoxime; Ceftizoxime; Cephalosporins; Clarithromycin; Enterobacteriaceae; Haemophilus influenzae; Humans; Levofloxacin; Ofloxacin; Penicillin G; Pharyngitis; Streptococcus pneumoniae; Streptococcus pyogenes; Tonsillitis	2003
Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2003, Volume: 35, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure	2003
Effects of eight antibacterial agents on cell survival and expression of epithelial-cell- or cell-adhesion-related genes in human gingival epithelial cells. Journal of periodontal research, 2004, Volume: 39, Issue:1 Topics: Anti-Bacterial Agents; Azithromycin; Cell Adhesion; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Clarithromycin; Enoxacin; Epithelial Cells; Erythromycin; Fibroblast Growth Factors; Gingiva; Humans; Integrins; Keratins; Laminin; Lethal Dose 50; Minocycline; Ofloxacin; Proteins; Roxithromycin; Tetracycline	2004
[Sporotrichoid atypical mycobacterial infections. Antibiotic monotherapy]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004, Volume: 55, Issue:3 Topics: Adult; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Female; Forearm; Hand Dermatoses; Humans; Levofloxacin; Lymphadenitis; Male; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Ofloxacin; Skin; Skin Diseases, Bacterial; Sporotrichosis; Treatment Outcome	2004
Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials. Pharmacoepidemiology and drug safety, 2005, Volume: 14, Issue:1 Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Arrhythmias, Cardiac; Case-Control Studies; Ciprofloxacin; Clarithromycin; Cohort Studies; Community Health Planning; Databases, Factual; Drug Monitoring; Erythromycin; Humans; Italy; Levofloxacin; Miocamycin; Norfloxacin; Ofloxacin; Pharmacoepidemiology; Risk Factors	2005
High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. International journal of antimicrobial agents, 2004, Volume: 24, Issue:5 Topics: Clarithromycin; Drug Resistance; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Nitroimidazoles; Ofloxacin; Proton Pump Inhibitors; Treatment Failure	2004
Antibiotics in exacerbations of COPD: lessons from the past. The European respiratory journal, 2004, Volume: 24, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Progression; Humans; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic	2004
An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care. Current medical research and opinion, 2005, Volume: 21, Issue:2 Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Databases as Topic; Erythromycin; Female; Health Care Costs; Humans; Levofloxacin; Male; Managed Care Programs; Middle Aged; Models, Econometric; Ofloxacin; Pneumonia, Bacterial; Retrospective Studies; Risk Assessment; Treatment Outcome	2005
[The clinical study on efficacy of clarithromycin, levofloxacin, and streptomycin for pulmonary Mycobacterium avium-intracellulare complex infection]. Kekkaku : [Tuberculosis], 2005, Volume: 80, Issue:1 Topics: Aged; Anti-Bacterial Agents; Blood Sedimentation; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Ofloxacin; Radiography, Thoracic; Retrospective Studies; Streptomycin	2005
In vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates. Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:2 Topics: Amoxicillin; Aza Compounds; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Sampling Studies; Sensitivity and Specificity; Streptococcus pneumoniae	2005
Ascites in the puerperium: a missed diagnosis of acute postpartum pancreatitis. Archives of gynecology and obstetrics, 2005, Volume: 272, Issue:3 Topics: Abdominal Pain; Acute Disease; Adult; Anti-Infective Agents; Ascites; Clarithromycin; Diagnosis, Differential; Female; Fever; Humans; Metronidazole; Ofloxacin; Pancreatitis; Postpartum Period; Treatment Outcome	2005
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis. International journal of antimicrobial agents, 2005, Volume: 26, Issue:4 Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis	2005
[Assessment of the management of community-acquired pneumonia in adults outpatients]. Revista medica de Chile, 2005, Volume: 133, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Chi-Square Distribution; Clarithromycin; Community-Acquired Infections; Emergencies; Female; Frail Elderly; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Prospective Studies; Treatment Failure	2005
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome. Chest, 2006, Volume: 129, Issue:3 Topics: Adult; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Israel; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Ofloxacin; Prognosis; Rifampin	2006
[Prevalence and treatment of pharyngeal Chlamydia trachomatis infections]. The Japanese journal of antibiotics, 2006, Volume: 59, Issue:1 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Female; Humans; Japan; Levofloxacin; Ofloxacin; Pharyngitis; Prevalence; Sex Work; Sexual Behavior; Uterine Diseases	2006
What are biofilms? Evaluation and management in open skin wounds. Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:6 Topics: Aged; Anti-Bacterial Agents; Biofilms; Clarithromycin; Drug Therapy, Combination; Foot Ulcer; Humans; Male; Ofloxacin; Pseudomonas aeruginosa; Radiotherapy; Sarcoma, Kaposi; Skin; Wound Healing	2006
Effects of antibacterial agents, levofloxacin and clarithromycin, on aquatic organisms. Water science and technology : a journal of the International Association on Water Pollution Research, 2006, Volume: 53, Issue:11 Topics: Animals; Anti-Bacterial Agents; Bacteria; Clarithromycin; Crustacea; Daphnia; Dose-Response Relationship, Drug; Environmental Pollutants; Levofloxacin; Models, Chemical; Ofloxacin; Risk; Toxicity Tests, Acute; Water Pollutants, Chemical; Water Purification	2006
Occurrence of levofloxacin, clarithromycin and azithromycin in wastewater treatment plant in Japan. Water science and technology : a journal of the International Association on Water Pollution Research, 2006, Volume: 53, Issue:11 Topics: Anti-Bacterial Agents; Azithromycin; Chromatography, Liquid; Clarithromycin; Conservation of Natural Resources; Japan; Levofloxacin; Mass Spectrometry; Ofloxacin; Sewage; Time Factors; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification	2006
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment. The American journal of gastroenterology, 2006, Volume: 101, Issue:8 Topics: Amoxicillin; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Omeprazole; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure	2006
[Basic evaluation for new antimicrobial susceptibility testing of Mycobacterium leprae by bioluminescence assay (ATP method)]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association, 2006, Volume: 75, Issue:3 Topics: Animals; Clarithromycin; Clofazimine; Drug Resistance, Bacterial; Leprostatic Agents; Leprosy; Luciferases; Luminescent Agents; Mice; Mice, Nude; Microbial Sensitivity Tests; Mycobacterium leprae; Ofloxacin; Rifampin	2006
[A case of Mycobacterium fortuitum meningitis following surgery for meningioma]. Rinsho shinkeigaku = Clinical neurology, 2006, Volume: 46, Issue:7 Topics: Clarithromycin; Female; Humans; Levofloxacin; Meningeal Neoplasms; Meningioma; Meningitis, Bacterial; Middle Aged; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Postoperative Complications	2006
Pacemaker infections due to rapidly growing mycobacteria: further experience. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2007, Volume: 11, Issue:1 Topics: Acetamides; Aged; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Linezolid; Mycobacterium Infections; Ofloxacin; Oxazolidinones; Pacemaker, Artificial; Prosthesis-Related Infections; Surgical Wound Infection	2007
Determination of six anti-infectives in wastewater using tandem solid-phase extraction and liquid chromatography-tandem mass spectrometry. Journal of environmental monitoring : JEM, 2007, Volume: 9, Issue:4 Topics: Anti-Infective Agents; Azithromycin; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Ofloxacin; Sewage; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Trimethoprim; Water Pollutants, Chemical	2007
Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Alimentary pharmacology & therapeutics, 2007, Jun-15, Volume: 25, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome	2007
Postoperative endophthalmitis caused by Bacillus cereus and Chlamydia trachomatis. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:7 Topics: Administration, Oral; Administration, Topical; Aged; Anti-Bacterial Agents; Bacillus cereus; Bacterial Typing Techniques; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Fluorescent Antibody Technique, Direct; Gram-Positive Bacterial Infections; Humans; Lens Implantation, Intraocular; Middle Aged; Ofloxacin; Oxytetracycline; Phacoemulsification; Polymyxin B; Postoperative Complications; Vitreous Body	2007
Levofloxacin in first-line treatment of Helicobacter pylori infection. Helicobacter, 2007, Volume: 12, Issue:4 Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Ofloxacin; Treatment Outcome	2007
In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Animals; Aza Compounds; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Humans; Japan; Levofloxacin; Liver; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolines; Spleen	2007
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Imipenem; Ketolides; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae	2007
Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2008, Volume: 12, Issue:2 Topics: Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Ethionamide; Female; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rwanda; Tuberculosis, Multidrug-Resistant	2008
Levofloxacin-resistant Helicobacter pylori in Hong Kong. Chemotherapy, 2008, Volume: 54, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA Gyrase; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Ketolides; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Point Mutation; Tetracycline	2008
[Case of pneumothorax associated with pulmonary Mycobacterium fortuitum infection]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2008, Volume: 82, Issue:2 Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Combined Modality Therapy; Drainage; Drug Resistance, Bacterial; Humans; Levofloxacin; Male; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Pneumonectomy; Pneumothorax; Recurrence; Treatment Outcome; Tuberculosis, Pulmonary	2008
In-vitro antimycobacterial drug susceptibility testing of non-tubercular mycobacteria by tetrazolium microplate assay. Annals of clinical microbiology and antimicrobials, 2008, Jul-11, Volume: 7 Topics: Agar; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Culture Media; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Reproducibility of Results; Species Specificity; Tetrazolium Salts; Time Factors	2008
Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates. Journal of clinical pathology, 2008, Volume: 61, Issue:10 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Case-Control Studies; Chi-Square Distribution; Clarithromycin; Colony Count, Microbial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Tetracycline Resistance; Treatment Failure	2008
[Levofloxacin and macrolides in chronic bronchitis exacerbation: comparative analysis of the treatment efficacy and nonrelapsing periods]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2007, Volume: 52, Issue:7-8 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Bronchitis, Chronic; Clarithromycin; Female; Humans; Levofloxacin; Macrolides; Male; Middle Aged; Ofloxacin; Treatment Outcome; Young Adult	2007
Levofloxacin-induced delirium. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2009, Volume: 30, Issue:2 Topics: Age Factors; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Brain; Clarithromycin; Confusion; Delirium; Ertapenem; Hallucinations; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia; Risk Factors; Sex Factors; Time Factors; Withholding Treatment	2009
[Antimicrobial resistance of 36 strains of Helicobacter pylori in adolescents]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2009, Volume: 11, Issue:3 Topics: Adolescent; Amoxicillin; Anti-Infective Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Female; Gastroscopy; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin	2009
Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication. The Netherlands journal of medicine, 2009, Volume: 67, Issue:3 Topics: Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors	2009
Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan. Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Asian People; Child; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Patient Selection; Prevalence; Taiwan; Time Factors; Treatment Failure; Young Adult	2009
Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Penicillins; Prospective Studies; Treatment Outcome	2010
Helicobacter pylori: antibiotic resistance and treatment options. Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:7 Topics: Amoxicillin; Anti-Bacterial Agents; Asian People; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Patient Selection; Prevalence; Taiwan; Time Factors; Treatment Failure	2009
Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori. Journal of clinical microbiology, 2009, Volume: 47, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Nucleic Acid Hybridization; Ofloxacin; Point Mutation; Predictive Value of Tests; Sensitivity and Specificity; Sequence Deletion	2009
Helicobacter pylori antibiotic resistance and [13C]urea breath test values. Journal of medical microbiology, 2010, Volume: 59, Issue:Pt 5 Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Statistics as Topic; Urea; Urease	2010
CEM-101 activity against Gram-positive organisms. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin	2010
Antibiotic resistance of Helicobacter pylori in Israeli children. Scandinavian journal of gastroenterology, 2010, Volume: 45, Issue:5 Topics: Adolescent; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Biopsy; Chi-Square Distribution; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Israel; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Prospective Studies; Surveys and Questionnaires; Tetracycline; Treatment Failure	2010
Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2010, Volume: 14, Issue:4 Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Chi-Square Distribution; Clarithromycin; Community-Acquired Infections; Female; Humans; Kaplan-Meier Estimate; Legionella pneumophila; Legionnaires' Disease; Length of Stay; Levofloxacin; Male; Ofloxacin; Retrospective Studies; Time Factors; Treatment Outcome	2010
Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication? Alimentary pharmacology & therapeutics, 2010, Volume: 31, Issue:11 Topics: Adolescent; Adult; Aged; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Tinidazole; Young Adult	2010
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11 Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline	2010
In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Anti-Infective Agents; Azithromycin; Chlamydia trachomatis; Clarithromycin; Doxycycline; Erythromycin; Genotype; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin	2010
Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases. Journal of infection and public health, 2010, Volume: 3, Issue:3 Topics: Aged; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Clarithromycin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lebanon; Levofloxacin; Male; Ofloxacin; Pneumococcal Infections; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Vancomycin	2010
Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai. World journal of gastroenterology, 2010, Oct-28, Volume: 16, Issue:40 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Retrospective Studies; Young Adult	2010
Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:3 Topics: Adult; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Randomized Controlled Trials as Topic; RNA, Ribosomal, 23S; Treatment Outcome	2011
Levofloxacin in first-line eradication regimens for Helicobacter pylori: better test antibiotic susceptibility before treating. Gut, 2011, Volume: 60, Issue:11 Topics: Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Ofloxacin	2011
Sequential therapy for Helicobacter pylori eradication: is levofloxacin better? Gut, 2011, Volume: 60, Issue:11 Topics: Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Ofloxacin	2011
In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4 Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bridged-Ring Compounds; Cell Line; Cells, Cultured; Clarithromycin; Disease Models, Animal; Humans; Ketolides; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Macrolides; Mice; Microbial Sensitivity Tests; Ofloxacin	2011
[Regional difference of antibiotic resistance of helicobacter pylori strains in Korea]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2011, Volume: 57, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Republic of Korea; Tetracycline	2011
Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:2 Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Doxycycline; Erythromycin; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Reproducibility of Results; Roxithromycin; Tetracycline; Time Factors; Ureaplasma Infections; Ureaplasma urealyticum	2011
High Helicobacter pylori resistance to metronidazole but zero or low resistance to clarithromycin, levofloxacin, and other antibiotics in Malaysia. Helicobacter, 2011, Volume: 16, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies	2011
Disseminated Mycobacterium haemophilum infection. The Lancet. Infectious diseases, 2011, Volume: 11, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Anti-HIV Agents; Cellulitis; Clarithromycin; HIV; Humans; Immunocompromised Host; Male; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections; Ofloxacin; Rifabutin	2011
Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland. Pharmacological reports : PR, 2011, Volume: 63, Issue:3 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Poland	2011
Buruli ulcer accompanied by pain in a Japanese patient. The Journal of dermatology, 2012, Volume: 39, Issue:10 Topics: Anti-Bacterial Agents; Asian People; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; Face; Female; Humans; Middle Aged; Mycobacterium ulcerans; Ofloxacin; Pain; Rifampin	2012
Metachronous Mycobacterium terrae complex tenosynovitis of the hand. The Journal of hand surgery, European volume, 2012, Volume: 37, Issue:6 Topics: Aged; Anti-Bacterial Agents; Blood Sedimentation; C-Reactive Protein; Clarithromycin; Hand; Histiocytes; Humans; Immunohistochemistry; Male; Mycobacterium Infections, Nontuberculous; Ofloxacin; Tenosynovitis	2012
Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered? Alimentary pharmacology & therapeutics, 2012, Volume: 35, Issue:10 Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Dyspepsia; Endoscopy; England; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Risk Factors; Wales	2012
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut, 2013, Volume: 62, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Utilization; Europe; Female; Helicobacter pylori; Humans; Infant; Infant, Newborn; Levofloxacin; Linear Models; Logistic Models; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Ofloxacin; Prospective Studies; Risk Factors; Surveys and Questionnaires; Young Adult	2013
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient. BMJ case reports, 2012, May-08, Volume: 2012 Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant	2012
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients. Journal of clinical gastroenterology, 2013, Volume: 47, Issue:2 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Logistic Models; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Spain; Surveys and Questionnaires; Time Factors; Treatment Failure	2013
Pulmonary Mycobacterium kyorinense disease showed clinical improvement following combined therapy with clarithromycin and levofloxacin. Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:14 Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Tuberculosis, Pulmonary	2012
Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. World journal of gastroenterology, 2012, Sep-07, Volume: 18, Issue:33 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Clarithromycin; Comorbidity; Disease Eradication; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors; Retrospective Studies; Tinidazole; Treatment Outcome; Ulcer; Young Adult	2012
Cumulative Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery. Obesity surgery, 2013, Volume: 23, Issue:2 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Obesity, Morbid; Ofloxacin; Portugal; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Factors; Stomach Neoplasms; Surgical Wound Infection; Treatment Failure; Young Adult	2013
Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients. Annals of clinical microbiology and antimicrobials, 2013, Jan-08, Volume: 12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Ofloxacin; RNA, Ribosomal, 23S; Senegal; Tetracycline; Young Adult	2013
Education and imaging. Gastrointestinal: colonic mucosa-associated lymphoid tissue lymphoma regressed by levofloxacin. Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colonic Neoplasms; Colonoscopy; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Endosonography; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lansoprazole; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Multimodal Imaging; Occult Blood; Ofloxacin; Polymerase Chain Reaction; Positron-Emission Tomography; Tomography, X-Ray Computed	2013
Antimicrobial effect of natural polyphenols with or without antibiotics on Chlamydia pneumoniae infection in vitro. Microbial drug resistance (Larchmont, N.Y.), 2014, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; Antioxidants; Cell Line, Tumor; Chlamydophila pneumoniae; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Epithelial Cells; Humans; Interleukin-17; Interleukin-23; Microbial Sensitivity Tests; Microbial Viability; Ofloxacin; Quercetin; Resveratrol; Stilbenes	2014
Antimicrobial Susceptibility of Microorganisms Isolated from Periapical Periodontitis Lesions. The Bulletin of Tokyo Dental College, 2016, Volume: 57, Issue:3 Topics: Actinomyces; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Biofilms; Campylobacter; Cefmetazole; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Fusobacteria; Haemophilus; Humans; Klebsiella; Microbial Sensitivity Tests; Ofloxacin; Periapical Periodontitis; Porphyromonas; Propionibacterium; Staphylococcus hominis; Veillonella	2016
Letter: levofloxacin resistance - a challenge for the treatment of Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 2017, Volume: 45, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Ofloxacin	2017
Peroxydisulfate activation by CuO pellets in a fixed-bed column, operating mode and assessments for antibiotics degradation and urban wastewater disinfection. Environmental science and pollution research international, 2022, Volume: 29, Issue:47 Topics: Amoxicillin; Anti-Bacterial Agents; Cephalexin; Clarithromycin; Copper; Disinfection; Escherichia coli; Ofloxacin; Oxidants; Oxides; Phenol; Sulfamethoxazole; Wastewater	2022
[Pollution Characteristics and Risk Assessment of Antibiotics in Beiyun River Basin in Beijing]. Huan jing ke xue= Huanjing kexue, 2023, Jun-08, Volume: 44, Issue:6 Topics: Anti-Bacterial Agents; Azithromycin; Beijing; Clarithromycin; Erythromycin; Lincomycin; Ofloxacin; Risk Assessment; Rivers; Roxithromycin; Sulfapyridine; Tandem Mass Spectrometry	2023